Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials

Antipsychotic-induced dyslipidemia could increase the risk of cardiovascular diseases. This is a meta-analysis of randomized double-blind placebo-controlled trials to examine the efficacy and safety of adjunctive metformin for dyslipidemia induced by antipsychotics in schizophrenia. The standardized...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Transl Psychiatry
Huvudupphovsmän: Jiang, Wen-Long, Cai, Dong-Bin, Yin, Fei, Zhang, Ling, Zhao, Xi-Wu, He, Jie, Ng, Chee H., Ungvari, Gabor S., Sim, Kang, Hu, Mei-Ling, Zheng, Wei, Xiang, Yu-Tao
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group UK 2020
Ämnen:
Review Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7181777/
https://ncbi.nlm.nih.gov/pubmed/32327628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-020-0785-y
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk